Literature DB >> 19433257

Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells.

Margarita M Ivanova1, Williard Mazhawidza, Susan M Dougherty, John D Minna, Carolyn M Klinge.   

Abstract

Gender differences in lung disease and cancer are well-established. We reported estrogenic transcriptional responses in lung adenocarcinoma cells from females but not males despite similar estrogen receptor (ER) expression. Here we tested the hypothesis that normal human bronchial epithelial cells (HBECs) show gender-independent estrogenic responses. We report that a small sample of HBECs express approximately twice as much ERbeta as ERalpha. ERalpha and ERbeta were located in the cytoplasm, nucleus, and mitochondria. In contrast to lung adenocarcinoma cells, estradiol (E2) induced estrogen response element (ERE)-mediated luciferase reporter activity in transiently transfected HBECs regardless of donor gender. Overexpression of ERalpha-VP16 increased ERE-mediated transcriptional activity in all HBECs. E2 increased and 4-hydroxytamoxifen and ICI 182,780 inhibited HBEC proliferation and cyclin D1 expression in a cell line-specific manner. In conclusion, the response of HBECs to ER ligands is gender-independent suggesting that estrogenic sensitivity may be acquired during lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433257      PMCID: PMC2767333          DOI: 10.1016/j.mce.2009.01.021

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  76 in total

1.  Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.

Authors:  J F Couse; J Lindzey; K Grandien; J A Gustafsson; K S Korach
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

2.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta.

Authors:  G G Kuiper; B Carlsson; K Grandien; E Enmark; J Häggblad; S Nilsson; J A Gustafsson
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

3.  A transcriptional co-repressor that interacts with nuclear hormone receptors.

Authors:  J D Chen; R M Evans
Journal:  Nature       Date:  1995-10-05       Impact factor: 49.962

4.  Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.

Authors:  L Nagy; H Y Kao; D Chakravarti; R J Lin; C A Hassig; D E Ayer; S L Schreiber; R M Evans
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

5.  17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells.

Authors:  L Altucci; R Addeo; L Cicatiello; S Dauvois; M G Parker; M Truss; M Beato; V Sica; F Bresciani; A Weisz
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

6.  Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells.

Authors:  J Hong; N N Shah; T J Thomas; M A Gallo; E J Yurkow; T Thomas
Journal:  Oncol Rep       Date:  1998 Sep-Oct       Impact factor: 3.906

Review 7.  Basic guide to the mechanisms of antiestrogen action.

Authors:  J I MacGregor; V C Jordan
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

8.  Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.

Authors:  D P McDonnell; D L Clemm; T Hermann; M E Goldman; J W Pike
Journal:  Mol Endocrinol       Date:  1995-06

9.  Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells.

Authors:  C K Watts; K J Sweeney; A Warlters; E A Musgrove; R L Sutherland
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Structure, expression, and chromosomal assignment of the human gene encoding nuclear respiratory factor 1.

Authors:  L Gopalakrishnan; R C Scarpulla
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

View more
  27 in total

1.  Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women.

Authors:  Susan E Olivo-Marston; Leah E Mechanic; Steen Mollerup; Elise D Bowman; Alan T Remaley; Michele R Forman; Vidar Skaug; Yun-Ling Zheng; Aage Haugen; Curtis C Harris
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

2.  The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.

Authors:  Nadiyah Kazmi; Diana C Márquez-Garbán; Lilia Aivazyan; Nalo Hamilton; Edward B Garon; Lee Goodglick; Richard J Pietras
Journal:  Lung Cancer Manag       Date:  2012-12

3.  Estrogen increases nitric-oxide production in human bronchial epithelium.

Authors:  Elizabeth A Townsend; Lucas W Meuchel; Michael A Thompson; Christina M Pabelick; Y S Prakash
Journal:  J Pharmacol Exp Ther       Date:  2011-09-22       Impact factor: 4.030

4.  Dehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptor.

Authors:  Yun Teng; Lacey M Litchfield; Margarita M Ivanova; Russell A Prough; Barbara J Clark; Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2014-05-17       Impact factor: 4.102

5.  Tamoxifen differentially regulates miR-29b-1 and miR-29a expression depending on endocrine-sensitivity in breast cancer cells.

Authors:  Penn Muluhngwi; Abirami Krishna; Stephany L Vittitow; Joshua T Napier; Kirsten M Richardson; Mackenzie Ellis; Justin L Mott; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2016-12-13       Impact factor: 8.679

6.  Sex Hormones and Lung Inflammation.

Authors:  Jorge Reyes-García; Luis M Montaño; Abril Carbajal-García; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.

Authors:  Andrew Hsu; Wenliang Zhang; Jen-Fu Lee; Jin An; Prasanna Ekambaram; Jingjing Liu; Kenneth V Honn; Carolyn M Klinge; Menq-Jer Lee
Journal:  Int J Oncol       Date:  2012-02-16       Impact factor: 5.650

8.  TGF-β/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression: IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION.

Authors:  Jiawei Zhao; Jingjing Liu; Jen-Fu Lee; Wenliang Zhang; Mustapha Kandouz; Garrett C VanHecke; Shiyou Chen; Young-Hoon Ahn; Fulvio Lonardo; Menq-Jer Lee
Journal:  J Biol Chem       Date:  2016-11-17       Impact factor: 5.157

9.  The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia.

Authors:  K S Lee; J Asgar; Y Zhang; M-K Chung; J Y Ro
Journal:  Neuroscience       Date:  2013-09-17       Impact factor: 3.590

10.  Estriol Reduces Pulmonary Immune Cell Recruitment and Inflammation to Protect Female Mice From Severe Influenza.

Authors:  Meghan S Vermillion; Rebecca L Ursin; Sarah E Attreed; Sabra L Klein
Journal:  Endocrinology       Date:  2018-09-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.